Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-41061 in Cardiac Edema (CHF)
NCT00462670Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Apr 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in edema secondary to heart failure and heart failure (HF) comparing Placebo with Tolvaptan 15mg (2 arms). Primary endpoint: Body Weight (Amount of Change) at Day 7. Started Apr 2007; status: completed.
02
Drugs
tolvaptan
03
Conditions
edema secondary to heart failureheart failure (HF)
Beyond the preview
Go deeper on NCT00462670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462670.